# Relovair PD PK in Chinese Healthy Subjects

> **NCT01711463** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 16 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Fluticasone Furoate/Vilanterol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01711463
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12-05
- **Primary completion:** 2013-06-04
- **Final completion:** 2013-06-04
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01711463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01711463, "Relovair PD PK in Chinese Healthy Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01711463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*